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A B S T R A C T
Renal ischemia/reperfusion (I/R) injury following kidney transplantation has been found to be a great clinical
problem owing to initiation of acute inflammatory responses and subsequently rapid loss of kidney function. It is
well known that lavender oil exhibits an extensive spectrum of pharmacological and biochemical activities. The
purpose of this study was to clarify molecular targets of lavender in treatment of this disease.
Male Wistar rats weighing 200–250 g were divided into three major groups: sham, I/R, and I/R+ different
doses of lavender oil (L1:50mg/kg, L2: 100mg/kg, and L3: 200mg/kg). A rat model of renal I/R (45min
ischemia and 24 h reperfusion) was created and lavender was administrated at 1 h after the beginning of re-
perfusion (i.p). Activities of antioxidant enzymes such as SOD, GPX, and CAT, and lipid peroxidation were
evaluated. The expression of inflammatory cytokines such as TNFα, IL1β, and IL10 was determined by IHC and
ELISA assay. Apoptosis activity and tissue damage were evaluated by TUNEL and H & E staining, respectively.
Our results showed that lavender oil markedly restored activities of antioxidant enzymes and reduced lipid
peroxidation (P < 0.05). Lavender significantly decreased levels of TNFα and IL1β and increased level of IL10
in a dose-dependent manner (P < 0.05). Lavender reduced TUNEL positive cells in a dose-dependent manner.
However, lavender reduced damage to peritubular capillaries and contributed to preservation of normal mor-
phology of renal cells.
In sum, our findings establish a fundamental foundation for future drug industry to decrease the rates of
rejection in kidney transplant patients.
1. Introduction
Renal ischemia/reperfusion (I/R) is a potential serious threat after
kidney transplantation which leads to graft dysfunction, and high
morbidity and mortality rate in early stages [1,2]. One of the core
manifestations of this complex syndrome is acute kidney injury that
occurs owing to rapid loss of kidney function by acute inflammatory
responses [3,4]. Additionally, after ischemia, reperfusion triggers a
pathophysiological cascades including burst release of intracellular
Ca2+ ion, excessive generation of free radicals and ROS, neutrophil
recruitment which, in turn, accelerate inflammation, sustained local
ischemia and cellular damage [5–8]. It has been reported that different
cellular signaling pathways are involved in I/R injury and other dis-
orders [9–13]. Among them, oxidative stress and inflammation play a
pivotal role in acute renal ischemia [14]. In fact, excessive production
of ROS leads to formation of a cytotoxic metabolite, peroxynitrite,
which can initiate multiple and irreversible consequences such as oxi-
dative DNA damage, necrotic and apoptotic cell death, and destruction
of membrane lipids owing to lipid peroxidation [15]. During lipid
peroxidation, abstraction of a hydrogen atom gives rise to lipid radical
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generation/propagation and subsequently formation of some break-
down products. Inflammation is a common abnormality in renal I/R
and displays a powerful role in its pathophysiology. Chemokines mainly
modulate the inflammation and subsequently secretion of pro-in-
flammatory cytokines, activation and infiltration of leukocyte, and ex-
pression of adhesion molecules. Pro-inflammatory cytokines such as
IL1β and TNFα are master mediators of renal dysfunction and damage
after I/R injury [16]. Therefore, inhibition of inflammatory responses
can be an efficient approach to reduce injury after reperfusion. Al-
though researchers have used many novel pharmacological agents and
methods in the laboratory to improve renal I/R and other diseases, only
a few of these agents or approaches have been translated to routine
clinical use [17–20]. Lavender, a flowering plant in the Labiatae (La-
miacae) family, is widely used in traditional medicine for centuries as a
herbal remedy [21]. There are four main categories for lavender: La-
vandula latifolia, Lavandula stoechas, Lavandula angustifolia,and La-
vandula x intermedia [22]. Lavender can act as antispasmodic, antic-
onvulsant, antidepressant, pain killer and carminative to treat various
diseases [23–25]. A recent study reported that the main constituent of
essential lavender oil was 1, 5-Dimethyl-1-vinyl-4-hexenyl butyrate.
However, the authors observed high antioxidant activity of essential
lavender oil against lipid peroxidation [26]. Currently, it has been re-
ported that lavender oil can reduce focal cerebral injury by targeting
apoptosis [27]. Additionally, it has been reported that lavender oil can
accelerate burn healing through modulating the balance of pro-in-
flammation and anti-inflammation cytokines [28]. On the basis of the
aforementioned studies, we went on to evaluate the protective effect of
lavender oil against renal I/R injury that has not been done so far. We
demonstrated that lavender oil exerts protective effects against renal I/
R injury by targeting pro-inflammatory and anti-inflammatory cyto-
kines, oxidative stress and apoptosis.
2. Materials and methods
2.1. Materials and chemicals
Natural Lavender oil from Lavandula angustifolia L and in situ Cell
Death Detection Kit were purchased from sigma chemical company.
Anti-TNF alpha antibody (ab6671, 1/200), Anti-IL1 beta antibody
(ab9722, 1/200), Anti-IL10 antibody (ab9969, 1/200) were obtained
from abcam company. Goat anti-rabbit IgG-FITC secondary antibody
was supplied by Santa Cruz Biotechnology's company. Rat TNFα ELISA
Kit, Rat IL-1β ELISA Kit, and Rat IL-10 ELISA Kit were purchased from
MyBioSource Company (San Diego, USA).
2.2. Animals and ethical statement
Male Wistar rats (200–250 g) were purchased from Animal Center of
Iran University of Medical Sciences. The animals were placed in a room
that the temperature (22 ± 2 °C) and humidity (62–65%) were main-
tained constantly and under a 12 h light and dark schedule. The animals
were fed with standard chow pellet and continuous access to water.
Prior to the experimental tests, School of Medicine Animal Care and Use
Committee of Iran University of Medical Sciences approved all the
protocols.
2.3. Experimental design
The animals were randomized into three major groups: a group of
animals received all surgical procedures except occlusion of renal artery
(sham group; n= 10); a group of rats were only endured occlusion of
renal artery for 45min and reperfusion for 24 h (I/R group; n=10);
three subgroups of the animals were subjected to occlusion of renal
artery and treated with different doses of lavender oil (L1, 50mg/kg;
L2, 100mg/kg; L3, 200mg/kg body weight). In the case of treatment
subgroups, different doses of lavender oil were intraperitoneally
administrated at 1 h after the beginning of reperfusion.
2.4. Surgical procedure
In brief, the animals were anesthetized with a mixture of ketamine
(50mg/kg) and xylazine (7.5 mg/kg).To keep core body temperature at
37 °C, the animals were placed on a homoeothermic table. The right
nephrectomy was carried out through a midline incision in upper ab-
dominal region. After 21 days, the animals were anesthetized again and
ischemia was induced through occlusion of the left renal pedicle. The
color changing of the kidney surface approved renal artery occlusion.
Humid and sterilized gauze was used to preserve kidney during 45min
ischemia. After 45min ischemia, the occlusion clip was released to
permit recirculation of blood flow for 24 h. At 24 h after reperfusion,
the animals were killed under deep anesthesia to collect tissue samples
for biochemical assessment including oxidative stress makers, and in-
flammatory cytokines.
2.5. Homogenization of tissues
At 24 h after reperfusion, the kidney tissues were rapidly dissected
and removed from the body on ice. The kidneys were washed with cold
saline solution and were weighed. Then, 150mg of the tissue was di-
vided and was homogenized within 1.5 mL phosphate buffer using a
homogenizer (IKA T18, Basic ULTRA TURRAX, USA) at 5000 rpm for
3min. In the next step, resulting solution was centrifuged. To decrease
the destruction of enzymes, all the mentioned above steps were per-
formed at 4 °C. After centrifuging, supernatant was separated and was
applied to determine oxidative stress markers and inflammation-asso-
ciated cytokines.
2.6. Assessment of CAT activity
A calorimetrically enzymatic assay kit at 405 nm (ZellBio GmbH,
Ulm, Germany) was used to measure CAT activity. The amount of the
sample that contributes to decomposition of 1 μmole of H2O2 to water
and O2 in one minute is considered as the CAT activity unit. The sen-
sitivity of this assay is about 0.5 U/mL.
2.7. Assessment of GPX activity
The Cayman Chemical Glutathione Peroxidase Assay Kit at 340 nm
(Cayman Chem, Ann Arbor, MI, USA) was used to determine GPX ac-
tivity. In this assay, measurement of GPX activity is based on a decrease
in absorbance at 340 nm owing to the oxidation of NADPH to NADP+.
GPX activity is expressed as U/mL.
2.8. Assessment of SOD activity
The measurement of SOD activity was performed using the Cayman
Chemical SOD Assay Kit (Cayman Chem, Ann Arbor, MI, USA) pursuant
to the manufacturer’s instructions. In this assay, the measurement of
SOD activity is based on measuring the dismutation of superoxide ra-
dicals generated by xanthine oxidase and hypoxanthine. The sensitivity
of this assay is about 0.005 U/ml.
2.9. Assessment of MDA
MDA level was measured using a commercial chemical color-
imetrical assay kit pursuant to the manufacturer’s instructions (ZellBio
GmbH, Ulm, Germany). In this assay, the reaction of MDA and TBA
under high temperature results in formation of the MDA-TBA adducts.
MDA level was determined in acidic media and heat (90–100 °C) col-
orimetrically at 532 (530–540 nm). The sensitivity of this assay is about
0.1 μM.
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2.10. Renal function
To evaluate renal function, serum BUN and Crlevels were measured.
At 24 h after reperfusion, blood samples were collected, centrifuged,
and kept at 20 °C prior to assessments. Serum levels of BUN and Cr were
determined by spectrophotometry using a commercial kit (Abbott
Laboratories) and an Architect c16000 Autoanalyzer (Abbottt
Laboratories, Abbottt Park, IL)
2.11. ELISA assay
The quantitative determination of inflammation-associated cyto-
kines (TNF-alpha, IL-1beta, and IL-10) was performed using commer-
cial colorimetric sandwich ELISA kits according to the manufacturer’s
instructions. In brief, samples and standards were pipetted into the
wells that been have pre-coated with specific antibodies for TNF-α, IL-
10 and IL1β. In next step, the wells were washed and enzyme-linked
antibodies specific for TNF-α, IL-10 and IL1β were added to wells and
incubated. Then, the wells were aspirated and washed. The process was
repeated three times. After the last washing, aspiration was performed
to remove any remaining wash buffer. The plate was inverted against
clean paper towels and any unbound antibody-enzyme reagent was
removed. Finally, a substrate solution containing equal volumes of
Reagents A and B was added to the wells and the solution was read at
450 nm using microplate reader.
2.12. Histological assessment
At the end of experiments, the animals were decapitated under deep
anesthesia and the kidney tissue samples were fixed in 10% formalin
overnight and embedded in paraffin. Then, serial sections of 5 μm
thickness were prepared by microtome [29,30]. Finally, H&E staining
of kidney sections was done to investigate histopathological changes. A
light microscope (Nikon Eclipse 80i; Tokyo, Japan) was used to in-
vestigate and photograph sections. Morphological evaluations were
performed by an experienced renal pathologist, who was blinded to
experimental design. Jablonski scores, a grading scale of 0–4, were used
for the histopathological evaluation of samples [31]. The scoring
system used is as follows: Score 0: Normal, Score 1: Mitosis and necrosis
of individual cells; Score 2: Necrosis of all cells in adjacent proximal
convoluted tubules, with survival of surrounding tubules; Score 3: Ne-
crosis confined to the distal third of the proximal convoluted tubule
with a band of necrosis extending across the inner cortex across the
inner cortex; Score 4: Necrosis affecting all three segments of the
proximal convoluted tubule.
2.13. IHC assay
To evaluate the expression of pro-inflammatory and anti-
inflammatory cytokines, the slices were deparaffinized and rehydrated.
Then, to block 5-micrometer sections, goat serum (10%) was used.
Sections were treated with primary antibody including Anti-TNF alpha
antibody (ab6671, 1/200), Anti-IL1 beta antibody (ab9722, 1/200),
Anti-IL10 antibody (ab9969, 1/200) at 1mg/ ml in 1% BSA/PBS for
60min. After twice washing with PBS, sections were incubated again
with specific horseradish peroxidase-conjugated secondary antibody for
20min A fluorescent microscopy (Olympus, Japan) was used to in-
vestigate and photograph sections. The nuclei of cells were stained by
DAPI. Data was analyzed using Image J software (NIH, Bethesda, MD,
USA).
2.14. Apoptosis assay
Determination of apoptosis in kidney tissues was based on enzy-
matic labeling of DNA strand breaks using Cell Death Detection kit in
consistent with the manufacturers' instructions. Summary, 5-micro-
meter paraffin sections were deparaffinized. Then, twice washing in
PBS (4min) was performed to rehydrate sections. Slices were incubated
with the permeabilization solution (0.1% Triton X-100 in 0.1% sodium
citrate) for 10min at 4 °C. After twice washing in PBS (5min), the la-
beling reaction was carried out by 50 μL TUNEL reagents at 37 °C for
60min against a blank containing all components except without en-
zyme. Then, after again washing with PBS, the slides were treated with
converter reagent for 20min at 37 °C. The nuclei of cells were stained
by DAPI. The TUNEL-positive apoptotic cells were counted in ten fields
per slide and 100 cells were counted per field blinded investigator to
experimental design. The apoptotic cells percentage or apoptosis index
(AI) was determined according to the following formula: AI = (the
number of apoptotic cells/the total number of counted cells) × 100%.
A fluorescence microscopy
(Olympus Corporation, Japan) was used to detect TUNEL-positive
cells. Data was analyzed using Image J software (NIH, Bethesda, MD,
USA).
2.15. Statistical analysis
All the variables are expressed as means ± SEM. Analysis of data
was carried out by using Prism Software, version 5. Comparison of three
or more groups was performed by One-way analysis of variance fol-
lowed by tukey test as post hoc analysis. Differences with a chance
probability of P < 0.05 were accepted statistically significant.
3. Results
3.1. The effect of lavender oil on serum levels of Cr and BUN
As depicted in Fig. 1A and B, serum levels of Cr and BUN were
significantly elevated in rats subjected to 45min ischemia and 24 h
Fig. 1. Post-treatment with 100 and 200mg/kg of lavender oil markedly improved kidney function by decreasing serum levels of Cr and BUN (*** p < 0.001 vs.
sham group; # p < 0.05 vs. I/R group; $$ p < 0. 01 vs. sham).
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reperfusion compared with sham-operated animals. Significant de-
creases in Cr and BUN levels were found in rats treated with the middle
(L2, 100mg/kg) and the highest (L3, 200mg/kg) tested concentrations
of lavender oil.
3.2. The effects of lavender oil on oxidative stress markers
As shown in Fig. 2A–C, significant decreased activities of SOD, GPX
and CAT were found in rats subjected to 45min ischemia and 24 h re-
perfusion. Intraperitoneally administration of different doses of la-
vender oil at 1 h after the beginning of reperfusion markedly restored
activities of SOD, GPX and CAT compared with I/R group. Our results
showed that lavender oil at 100mg/kg concentration exerted greatest
protective effect against renal I/R injury. Moreover, we found that ac-
tivity of SOD showed a significant decreased activity at the highest
tested dose (L3, 200mg/kg) compared with middle tested dose (L2,
100mg/kg). Additionally, MDA level was significantly increased in I/R
group relative to sham (Fig. 2D). Lavender oil post-treatment at various
concentrations markedly reduced MDA levels compared with I/R
group. A stronger reduced level of MDA was observed in middle tested
dose (L2, 100mg/kg) compared with the highest tested dose (L3,
200mg/kg).
3.3. The effects of lavender oil on TNFα
Generally, IHC assay showed that the expression of TNFα was in-
creased following I/R and reversed by different doses of lavender oil
(Fig. 3A). The quantitative determination of TNFα expression was
performed by ELISA assay. As depicted in Fig. 3B, the expression of
TNFα was significantly increased in rats subjected to renal I/R com-
pared with sham. Although lavender oil administration at the lowest
tested dose decreased the expression of TNFα, the difference did not
show a significant level. Middle and the highest tested doses of lavender
oil markedly decreased the expression of TNFα compared with I/R
group. There was no significant difference between middle and the
highest doses of lavender oil and sham group.
3.4. The effect of lavender oil on IL1β
Similar to TNFα, IHC assay indicated that the expression of IL1β
was increased in rats subjected to renal I/R and reversed by various
tested concentrations of lavender oil (Fig. 4A). Additionally, the
quantitative analysis by ELISA demonstrated that the expression of IL1β
was markedly increased in renal I/R group compared with sham. The
expression level of IL1β was slightly decreased after treatment with the
lowest tested dose of lavender oil (50mg/kg) and no significant dif-
ference was observed. Both middle and the highest tested doses of la-
vender oil were significantly reduced the expression level of IL1β. There
was a remarkable difference between sham and the lowest tested dose
of lavender oil (L1) (Fig. 4B).
3.5. The effects of lavender oil on IL10
IHC analysis demonstrated that the expression level of IL10 was
decreased following I/R and reversed by different tested concentrations
of lavender oil (Fig. 5A). Likewise, the quantitative determination of
this anti-inflammatory cytokine by ELISA analysis showed that the
expression of IL10 was significantly decreased in rats subjected to I/R
compared with sham. Significant increased levels of IL10 were found
after administration of middle and the highest tested doses of lavender
oil (100 and 200mg/kg) (Fig. 5B).
3.6. The effects of lavender oil apoptosis activity
In order to evaluate the effects of lavender oil on renal I/R injury,
we performed TUNEL. The number of TUNEL positive cells was mark-
edly increased in I/R group. Intraperitoneal administration of lavender
oil at doses of 100 and 200mg/kg significantly reduced apoptotic cell
death. The highest tested dose of lavender oil exhibited a stronger effect
for inhibition of apoptosis (Fig. 6).
3.7. The effect of lavender oil on tissue damage
As illustrated at Fig. 7, forty-five minutes renal ischemia followed by
Fig. 2. Lavender oil post-treatment sig-
nificantly restored activity of antioxidant en-
zymes and decreased lipid peroxidation. (A)
SOD activity (*** p < 0.001 vs. sham group;
### p < 0.001 vs. I/R group; &&&
p < 0.001 vs. L1), (B) GPX activity (***
p < 0.001 vs. sham group; ### p < 0.001
vs. I/R group; $$$ p < 0.001 vs. sham; &
p < 0.05 vs. L2), (C) CAT activity (***
p < 0.001 vs. sham group; ### p < 0.001
vs. I/R group; $$$ p < 0.001 vs. sham; &
p < 0.05 vs.L1), (D) MDA level (***
p < 0.001 vs. sham group; ### p < 0.001
vs. I/R group; $ p < 0.05 vs. sham and L1; $$
p < 0. 01 vs.L2).
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Fig. 3. Post-treatment with 100 and 200mg/kg of lavender oil significantly decreased the expression of TNFα 24 h after reperfusion. (A) IHC assay, and (B) ELISA
analysis of the TNF-α in different groups at 24 h after reperfusion (*** p < 0.001 and $$ p < 0. 01 vs. sham group; #p < 0. 05 and ##p < 0. 01 vs. I/R group; &
p < 0.05 vs. L1).
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Fig. 4. Lavender oil post-treatment decreased the expression of IL1β at 24 h after reperfusion. (A) IHC assay, and (B) ELISA analysis of the IL1β in different groups at
24 h after reperfusion (*** p < 0.001 and $$ p < 0. 01 vs. sham group; #p < 0. 05 and ##p < 0. 01 vs. I/R group; & p < 0.05 vs. L1).
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Fig. 5. Lavender oil administration at 1 h after the beginning of reperfusion increased the expression of IL10. (A) IHC assay, and (B) ELISA analysis of the IL10 in
different groups at 24 h after reperfusion (** p < 0. 01 vs. sham group; $$ p < 0. 01 vs. sham; ## p < 0. 01 vs. I/R group).
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Fig. 6. Lavender oil reduced apoptotic cell death in a dose dependent mechanism (***p < 0. 001 vs. sham group; #p < 0. 05, ###p < 0. 001 vs. I/R group; $$$
p < 0.001 vs.L1).
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24 h reperfusion induced severe damage including tn and hg at 24 h
post-IR in kidney tissue. A significant reduced tissue damage and pre-
servation of morphology were seen in L2 (100mg/kg) and L3 (200mg/
kg). According to Jablonski scores, quantitative analysis demonstrated
a significantly increased score in the I/R group. Intraperitoneal ad-
ministration of lavender oil at doses of 100 and 200mg/kg markedly
reduced the score.
4. Discussion
In this study, we for the first time examined the effects of lavender
oil on renal injury that was induced in a rat model of renal I/R injury.
Some factors such as oxidative stress markers, expression of pro and
anti-inflammatory markers and apoptotic cell death have been de-
termined. Also, renal I/R triggered a pathological cascade including
enhancement of oxidative stress, initiation of acute inflammatory re-
sponses, massive tubular damage, apoptotic cell death and subse-
quently renal failure. Our results demonstrated that intraperitoneally
lavender oil administration markedly improved kidney function and
promoted cell survival through targeting oxidative stress, inflammatory
cytokines, and apoptosis. A suitable option for end-stage renal disorders
is kidney transplantation. Renal I/R injury is a great clinical problem
after kidney transplantation which causes acute inflammatory response
and subsequently decreases efficiency of this option [32–34]. Renal
cells are very sensitive to alterations in oxygen tension and their en-
dogenous antioxidant defense strongly depends on presence of high
concentrations of antioxidant enzymes such as SOD, CAT, and GPx
[35]. Many previous studies have shown that even delayed adminis-
tration of free-radical scavenger drug reduces injury after renal I/R in
animal models. This issue confirms the key role of ROS in enhancement
of injury after renal I/R [36]. Excessive generation of ROS overcomes
endogenous antioxidant defense which, in turn, results in ATP deple-
tion, higher activity of membrane phospholipids proteases, elevated
level of intracellular Ca2+ ion, alterations of mitochondrial oxidative
phosphorylation [37]. Additionally, oxygen free radicals enhance in-
jury membrane lipid peroxidation, protein oxidation and oxidative
damage of DNA [38]. Under oxidative stress, superoxide anion (O−2 )
interacts with NO and disrupts nitroso-redox imbalance. This imbalance
leads to generation of reactive compounds like peroxynitrite. Oxidation
of lipids can be a consequence of peroxynitrite formation [39]. In this
study, our results showed that induction of renal I/R injury markedly
decreased activities of antioxidant enzymes such as SOD, CAT, and GPx
and enhanced lipid peroxidation. Intraperitoneal injection of various
concentrations of lavender oil contributes to activity restoration of
antioxidant enzymes and inhibition of lipid peroxidation. In keeping
with our findings, many previous studies have indicated that smelling
or inhalation of lavender oil can exert protective effects against de-
mentia, diabetes, and myocardial infarction by increasing free radical
scavenging activity and targeting oxidative stress [40–42]. After re-
perfusion, owing to hypoxic cellular injury, secretion of some factors
and structural alterations in cell surfaces or proteins evokes the immune
system. In fact, during reperfusion, necrotic or injured renal cells in-
itiate release of some factors such as high mobility group 1 protein that
is a strong stimulator of leukocyte infiltration and TNF-α production.
On the other hand, production of IL1β can evoke the TECs to produce
TNF-α and IL-6 that, in turn, result in extension of injury [43]. A study
by Jevnikar et al. reported that IL-18 acts as a stimulator of TECs for the
secretion of pro-inflammatory cytokines including IL-1β, TNFa, and IL-
6 which are hallmarks of renal I/R and exacerbate injury [44]. In
consistent with previous studies, our findings showed that expression
levels of pro-inflammatory cytokines were markedly elevated in rats
subjected to renal I/R injury and reversed by various concentrations of
lavender oil. In the case of inflammatory cytokines, the protection was
in dose dependent manner. On the other hand, previous studies have
shown overexpression of IL-10 after reperfusion can reduce neutrophil
recruitment and secretion of pro-inflammatory cytokines [45]. A recent
study by Soranno et al. showed that using injectable hydrogels as car-
riers for delivery of IL-10 to the ischemic kidney improved renal
Fig. 7. Hematoxylin and eosin stained kidney sections. Ischemic changes including tubular necrosis (tn) and hemorrhage (hg) were highly observed in I/R and L1
groups at 24 h post-IR. Lavender administration at middle and the highest doses significantly decreased tissue damage. Jablonski scores demonstrated markedly
increased scores in I/R compared to sham. Significant decreased scores were found in middle and the highest tested doses of lavender oil (100 and 200mg/kg) (***
p < 0.001 and $$ p < 0. 01 vs. sham group; #p < 0. 05 vs. I/R group).
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outcomes by targeting systemic inflammation [46]. According to these
previous findings, our study demonstrated that post-treatment with
lavender oil increased the expression of IL-10 in a dose-dependent
mechanism. In consistent with our findings, some previous studies have
indicated that lavender reduced LPS-Stimulated Inflammation by tar-
geting pro-inflammatory cytokines and membrane Toll-like receptors
[47]. To obtain greater insights of protective effects of lavender oil
against renal I/R injury, we also investigated apoptosis activity using
TUNEL staining in different groups. The kidneys of the I/R group had
more TUNEL positive cells relative to sham. Our findings showed that
intraperitoneal administration of lavender oil reduced apoptotic cell
death in a dose-dependent manner. In agreement with our results,
Vakili et al. reported that lavender oil exerted neuroprotective effects
on an animal model of ischemic stroke through inhibition of apoptosis
[27]. Our results demonstrated that lavender oil reduced damage to
peritubular capillaries, tubular necrosis, and preserved normal mor-
phology of nephrons.
5. Conclusion
Collectively, our findings demonstrate that lavender oil can act as a
potent anti-inflammatory agent against renal I/R injury. Moreover, it
can reduce injury through targeting oxidative stress and apoptosis.
Lavender oil can be presented as a good candidate for future drug de-
sign to accelerate recovery of kidney function after kidney transplan-
tation.
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